Factors associated with ASDAS remission in a long-term study of ankylosing spondylitis patients under tumor necrosis factor inhibitors

Term Study ◽

Factors Associated ◽

Long Term Study ◽

Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study

Dermatology ◽

10.1159/000345623 ◽

2012 ◽

Vol 225 (4) ◽

pp. 312-319 ◽

Cited By ~ 48

Author(s):

Maria Esposito ◽

Alessandro Giunta ◽

Annamaria Mazzotta ◽

Arianna Zangrilli ◽

Graziella Babino ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Efficacy And Safety ◽

Term Study ◽

Necrosis Factor Alpha ◽

Long Term Study ◽

Factor Alpha ◽

AB1120 Comparison of Long-Term Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis: A Single Center Turkish Experience Over a Decade

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.5898 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 1275.2-1276

Author(s):

G. Can ◽

S. Capar ◽

P. Cetin ◽

D. Solmaz ◽

G. Kenar ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Psoriatic Arthritis ◽

Ankylosing Spondylitis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Single Center ◽

Drug Survival ◽

The role of antinuclear autoantibodies in patients with psoriasis treated with anti–tumor necrosis factor-alpha agents: A retrospective long-term study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2011.06.008 ◽

2012 ◽

Vol 66 (5) ◽

pp. e180-e182 ◽

Cited By ~ 8

Author(s):

Rosita Saraceno ◽

Francesca Specchio ◽

Tiago Torres ◽

Steven Paul Nisticò ◽

Stefano Rizza ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Term Study ◽

Necrosis Factor Alpha ◽

Long Term Study ◽

Antinuclear Autoantibodies ◽

Factor Alpha ◽

Active immunization to tumor necrosis factor-α is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis

Arthritis Research & Therapy ◽

10.1186/ar2897 ◽

2009 ◽

Vol 11 (6) ◽

pp. R195 ◽

Cited By ~ 20

Author(s):

Laure Delavallée ◽

Luca Semerano ◽

Eric Assier ◽

Géraldine Vogel ◽

Grégoire Vuagniaux ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Inflammatory Disease ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Active Immunization ◽

Term Study ◽

Long Term Study ◽

Factor Α ◽

Faculty Opinions recommendation of Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2740956.2403058 ◽

2010 ◽

Author(s):

Ulf Müller-Ladner

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Active Immunization ◽

Term Study ◽

Necrosis Factor Alpha ◽

Long Term Study ◽

Factor Alpha ◽

Rebuttal letter on “Comment on Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature”

Clinical Rheumatology ◽

10.1007/s10067-021-05705-8 ◽

2021 ◽

Author(s):

Francisco Airton Castro Rocha ◽

Atul Deodhar

Keyword(s):

Ankylosing Spondylitis ◽

Tumor Necrosis Factor ◽

Structural Damage ◽

Tumor Necrosis ◽

Treatment Guidelines ◽

Case Series ◽

Review Of Literature ◽

FRI0416 Effect of treatment with tumor necrosis factor inhibitors (TNFI) on bone mineral density (BMD) in patients with ankylosing spondylitis (AS) : a systematic review.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.1543 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A514.2-A514

Author(s):

N. Nigil Haroon ◽

N. AlGhanim ◽

R. D. Inman ◽

A. M. Cheung

Keyword(s):

Bone Mineral Density ◽

Systematic Review ◽

Ankylosing Spondylitis ◽

Tumor Necrosis Factor ◽

Bone Mineral ◽

Tumor Necrosis ◽

Mineral Density ◽

Effect Of Treatment ◽

Preventive effect of tumor necrosis factor inhibitors versus nonsteroidal anti-inflammatory drugs on uveitis in patients with ankylosing spondylitis

Clinical Rheumatology ◽

10.1007/s10067-018-4249-1 ◽

2018 ◽

Vol 37 (10) ◽

pp. 2763-2770 ◽

Cited By ~ 3

Author(s):

Min Jung Kim ◽

Eunyoung Emily Lee ◽

Eun Young Lee ◽

Yeong Wook Song ◽

Hyeong Gon Yu ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Preventive Effect ◽

Inflammatory Drugs ◽

Anti Inflammatory ◽

Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis

Advances in Therapy ◽

10.1007/s12325-018-0869-8 ◽

2019 ◽

Vol 36 (3) ◽

pp. 721-745

Author(s):

László Gulácsi ◽

Zsombor Zrubka ◽

Valentin Brodszky ◽

Fanni Rencz ◽

Rieke Alten ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Literature Review ◽

Systematic Literature Review ◽

Tumor Necrosis ◽

Meta Analysis ◽

Term Efficacy ◽

Dose reduction of recombinant human tumor necrosis factor inhibitors (etanercept) can be effective in ankylosing spondylitis patients with synovitis of the hip in a Chinese population

International Journal of Immunopathology and Pharmacology ◽

10.1177/0394632016656013 ◽

2016 ◽

Vol 29 (3) ◽

pp. 510-515 ◽

Cited By ~ 7

Author(s):

Jitian Li ◽

Xiaoqing Wang ◽

Zongchang Han ◽

Yonghong Zhang ◽

Yuli Wang ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Tumor Necrosis Factor ◽

Dose Reduction ◽

Chinese Population ◽

Tumor Necrosis ◽

Human Tumor ◽

Human Tumor Necrosis Factor ◽